ibrutinib,rituximab
abbvie,janssen
[' ibru', 'ritux']
#ash22 plenary session martin dreyling presents study design for the triangle study. quotes what a nice view from the podium and no one likes autologous transplant . 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.